NCT03227146View on ClinicalTrials.gov

Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

November 30, 2022

Study Completion Date

August 31, 2025

Conditions
Burns
Interventions
BIOLOGICAL

EHSG-KF

Transplantation of autologous dermo-epidermal skin substitute EHSG-KF to the experimental area

BIOLOGICAL

STSG

Transplantation of autologous split-thickness skin graft to the control area

Trial Locations (6)

1940

Rode Kruis Ziekenhuis, Beverwijk

3079

Maasstad Ziekenhuis, Rotterdam

8032

University Children's Hospital Zurich, Zurich

8091

University Hospital Zurich, Zurich

Unknown

Chirurgia Plastica e Centro Grandi Ustioni Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli

Unità di Chirurgia Plastica e Ustioni Ospedale Santobono, Napoli

Sponsors

Collaborators (1)

Julius Clinical
All Listed Sponsors
collaborator

Wyss Zurich

UNKNOWN

collaborator

Julius Clinical

INDUSTRY

collaborator

Sintesi Research Srl

INDUSTRY

collaborator

University Hospital, Zürich

OTHER

collaborator

University of Zurich

OTHER

lead

CUTISS AG

INDUSTRY

NCT03227146 - Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents | Biotech Hunter | Biotech Hunter